Evidence map›Paper›PMID 34912009›Full record

ArticleScientific reports2021

Research on expansion and classification of imbalanced data based on SMOTE algorithm.

Shujuan Wang, Yuntao Dai, Jihong Shen, Jingxue Xuan

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An explainable machine learning approach to predicting carbapenem resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shujuan WangCollege of Mathematical Sciences, Harbin Engineering University, Harbin, 150001, China.
Yuntao DaiCollege of Mathematical Sciences, Harbin Engineering University, Harbin, 150001, China.
Jihong ShenCollege of Mathematical Sciences, Harbin Engineering University, Harbin, 150001, China.
Jingxue XuanCollege of Science, Qiqihar University, Qiqihar, 161006, China. xuanjingxue@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the development of artificial intelligence, big data classification technology provides the advantageous help for the medicine auxiliary diagnosis research. While due to the different conditions in the different sample collection, the medical big data is often imbalanced. The class-imbalance problem has been reported as a serious obstacle to the classification performance of many standard learning algorithms. SMOTE algorithm could be used to generate sample points randomly to improve imbalance rate, but its application is affected by the marginalization generation and blindness of parameter selection. Focusing on this problem, an improved SMOTE algorithm based on Normal distribution is proposed in this paper, so that the new sample points are distributed closer to the center of the minority sample with a higher probability to avoid the marginalization of the expanded data. Experiments show that the classification effect is better when use proposed algorithm to expand the imbalanced dataset of Pima, WDBC, WPBC, Ionosphere and Breast-cancer-wisconsin than the original SMOTE algorithm. In addition, the parameter selection of the proposed algorithm is analyzed and it is found that the classification effect is the best when the distribution characteristics of the original data was maintained best by selecting appropriate parameters in our designed experiments.

Identifiers

PMID34912009
PMCPMC8674253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.